Previous 10 | Next 10 |
The following slide deck was published by SI-BONE, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: SI-BONE, Inc. 2021 Q3 - Results - Earnings Call Presentation
SI-BONE, Inc. (SIBN) Q3 2021 Earnings Conference Call November 08, 2021 4:30 PM ET Company Participants Matt Bacso – Gilmartin Group Laura Francis – Chief Executive Officer Anshul Maheshwari – Chief Financial Officer Conference Call Participants Brandon Folkes – Ca...
SI-BONE (NASDAQ:SIBN): Q3 GAAP EPS of -$0.48 misses by $0.07. Revenue of $22.3M (+9.5% Y/Y) misses by $0.19M. Press Release For further details see: SI-BONE EPS misses by $0.07, misses on revenue
SANTA CLARA, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended September 30, 2021. Recent Highlights ...
SANTA CLARA, Calif., Oct. 18, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the third quarter of 2021 after market close on Monda...
SANTA CLARA, Calif., Oct. 11, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN) a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacro-pelvic anatomy, today announced that UnitedHealthcare has changed its minimally invasive SI joint fu...
SANTA CLARA, Calif., Aug. 23, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that it will be participating in the following upcoming investor conferences: ...
The following slide deck was published by SI-BONE, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: SI-BONE, Inc. 2021 Q2 - Results - Earnings Call Presentation
SI-BONE, Inc. (SIBN) Q2 2021 Earnings Conference Call August 02, 2021, 16:30 ET Company Participants Matthew Bacso - Gilmartin Group Laura Francis - CEO & Director Anshul Maheshwari - CFO Conference Call Participants Robert Hopkins - Bank of America Merrill Lynch Kyle Rose - Canaccord Gen...
SI-BONE (NASDAQ:SIBN): Q2 GAAP EPS of -$0.42 misses by $0.02. Revenue of $22.19M (+57.9% Y/Y) beats by $0.46M. Cash and marketable securities were $176.6 million and long-term borrowings were $39.6 million as of June 30, 2021. 2021 Guidance: The Company continues to take a measured appro...
News, Short Squeeze, Breakout and More Instantly...
SANTA CLARA, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the second quarter of 2024 after market close on Monday, Au...
2024-07-04 13:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-14 15:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...